Abstract
4-Amino-5,6-biaryl-furo[2,3-d]pyrimidines were identified as potent non-selective inhibitors of Lck. A novel, divergent, and practical synthetic route was developed to access derivatives from bifunctional intermediates. Lead optimization was guided by X-ray crystallographic data, and preliminary SAR led to the identification of compounds with improved cellular potency and selectivity.
MeSH terms
-
Animals
-
Anti-Inflammatory Agents / chemical synthesis
-
Humans
-
Inhibitory Concentration 50
-
Interleukin-2 / metabolism
-
Lymphocyte Culture Test, Mixed
-
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) / antagonists & inhibitors*
-
Lymphocytes / drug effects
-
Pharmacokinetics
-
Protein Kinase Inhibitors / chemical synthesis
-
Protein Kinase Inhibitors / pharmacokinetics
-
Pyrimidines / chemical synthesis*
-
Pyrimidines / pharmacokinetics*
-
Quantitative Structure-Activity Relationship*
-
Rats
-
Rats, Sprague-Dawley
Substances
-
Anti-Inflammatory Agents
-
Interleukin-2
-
Protein Kinase Inhibitors
-
Pyrimidines
-
Lymphocyte Specific Protein Tyrosine Kinase p56(lck)